Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
TNXP
↓ PDF (Pro)Tonix Pharmaceuticals Holding Corp. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$14.48
+7.26%today
MKT CAP
$206M
+9.5% · 1Y
Earnings History
+14.5%
-112.8%
-34.4%
-35.4%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$14.48
Low
$22.00
Analyst Mean
$46.25
High
$65.00
4 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-1.8x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ+63.8%
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership0.1%
Institutional Ownership24.6%
Short % of Float17.46%
Days to Cover4.8d
1 Week+4.8%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| LEDERMAN SETH | Chief Executive Officer | Buy | 5,000 | $12.62 | $0.06M | 2026-03-31 |
| LEDERMAN SETH | Chief Executive Officer | Buy | 15,000 | $14.89 | $0.22M | 2026-03-18 |
| SAENGER BRADLEY | Chief Financial Officer | Stock | 701 | $13.42 | $0.01M | 2025-12-31 |
| TAYLOR CAROLYN E. | Director | Buy | 418 | $36.03 | $0.02M | 2025-08-21 |
| TRECO JAMES | Director | Buy | 250 | $36.00 | $0.01M | 2025-08-20 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Blackrock Inc. | institution | 6.60% | $0.01B | +29.84% | 2025-12-31 |
| Vanguard Group Inc | institution | 5.02% | $0.01B | +20.94% | 2025-12-31 |
| Point72 Asset Management, L.P. | institution | 4.63% | $0.01B | +100.00% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.57% | $0.00B | +19.96% | 2025-12-31 |
| iShares Trust-iShares Russell 2000 ETF | fund | 2.44% | $0.00B | +12.57% | 2026-03-31 |
| Geode Capital Management, LLC | institution | 2.03% | $0.00B | +35.32% | 2025-12-31 |
| State Street Corporation | institution | 1.43% | $0.00B | +25.77% | 2025-12-31 |
| Balyasny Asset Management LP | institution | 1.38% | $0.00B | +100.00% | 2025-12-31 |
| Northern Trust Corporation | institution | 1.30% | $0.00B | +3.06% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.96% | $0.00B | +30.90% | 2025-12-31 |
| iShares Trust-iShares Russell 2000 Value ETF | fund | 0.87% | $0.00B | +18.73% | 2026-03-31 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | fund | 0.84% | $0.00B | -1.41% | 2026-01-31 |
| Nuveen, LLC | institution | 0.71% | $0.00B | +1.24% | 2026-03-31 |
| UBS Group AG | institution | 0.68% | $0.00B | +77.31% | 2025-12-31 |
| Davidson Kempner Capital Management LP | institution | 0.67% | $0.00B | +100.00% | 2025-12-31 |
| Northern Funds-SMALL CAP VALUE FUND | fund | 0.60% | $0.00B | -6.10% | 2025-12-31 |
| TIAA-CREF Funds-Nuveen Equity Index Fund | fund | 0.50% | $0.00B | +1523.18% | 2026-01-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | fund | 0.46% | $0.00B | -0.36% | 2026-02-28 |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | fund | 0.43% | $0.00B | +32.35% | 2026-02-28 |
| iShares Trust-iShares Micro-Cap ETF | fund | 0.25% | $0.00B | +10.22% | 2026-03-31 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for TNXP.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.